Enigma Diagnostics Limited - Product Pipeline Analysis, 2016 Update

Summary

Enigma Diagnostics Limited (Enigma) is a medical device company that offers diagnostic instrument. The company manufactures and markets molecular diagnostic instruments for detection and identification of infectious organisms. It develops molecular diagnostic instrument platforms. Enigma develops Enigma Mini Laboratory system which combines the speed and sensitivity of polymerase chain reaction. The company has pipeline of multiplexed assays for sexually transmitted diseases, respiratory diseases, and hospital acquired infections. It offers real-time PCR diagnostic testing for laboratories, local hospitals, at point-of-care locations. The company operates in the US and the UK. Enigma is headquartered in Salisbury, the UK.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Enigma Diagnostics Limited
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio


Table of Contents
List of Tables
List of Figures
Enigma Diagnostics Limited Company Snapshot
Enigma Diagnostics Limited Company Overview
Enigma Diagnostics Limited Pipeline Products and Clinical Trials Overview
Enigma Diagnostics Limited – Pipeline Analysis Overview
Key Facts
Enigma Diagnostics Limited - Major Products and Services
Enigma Diagnostics Limited Pipeline Products by Development Stage
Enigma Diagnostics Limited Pipeline Products Overview
Enigma ML - C. Difficile/Norovirus
Enigma ML - C. Difficile/Norovirus Product Overview
Enigma ML - CT/NG
Enigma ML - CT/NG Product Overview
Enigma ML - HPV
Enigma ML - HPV Product Overview
Enigma ML - MRSA
Enigma ML - MRSA Product Overview
Enigma ML - Rhinovirus
Enigma ML - Rhinovirus Product Overview
Enigma ML - Tuberculosis DST Detestion Assay
Enigma ML - Tuberculosis DST Detestion Assay Product Overview
Enigma ML System
Enigma ML System Product Overview
Enigma ML System - FluAB-RSV Diagnostic Assay
Enigma ML System - FluAB-RSV Diagnostic Assay Product Overview
Enigma XL System
Enigma XL System Product Overview
MDx Infectious Disease Assay
MDx Infectious Disease Assay Product Overview
ResonSense MDR-TB Assay
ResonSense MDR-TB Assay Product Overview
Enigma Diagnostics Limited - Key Competitors
Enigma Diagnostics Limited - Key Employees
Enigma Diagnostics Limited - Locations And Subsidiaries
Head Office
Recent Developments
Enigma Diagnostics Limited, Recent Developments
Jan 14, 2014: Enigma Diagnostics CE marks the Enigma ML system and its first multiplexed assay detecting Influenza A, Influenza B and RSV
Jul 29, 2013: Enigma Diagnostics Announces Successful Completion of Flagship Enigma ML System Evaluation at Guy's and St. Thomas' NHS Foundation Trust, London, UK
Dec 07, 2012: Enigma Diagnostics receives Biomedical Catalyst grant to develop multi drug resistant TB assay using proprietary ResonSense technology
Jul 18, 2011: Enigma Completes RANGER Project Based On Enigma ML-Influenza A/B
Apr 11, 2011: Enigma Announces Start Of US Clinical Trials For Influenza A/B Detection Assay
Apr 11, 2011: Enigma Announces Start Of US Clinical Trials For Influenza A/B Detection Assay
Oct 19, 2010: Enigma Diagnostics' Patents Maintained By UK IPO
Apr 22, 2010: Enigma Diagnostics To Showcase Enigma ML At InnovHealth Summit 2010 In Abu Dhabi
Apr 19, 2010: Enigma Diagnostics Gets US Patent Grant Covering Amplification Consumables
Mar 04, 2010: Enigma Diagnostics Appoints Joel Centeno As VP Regulatory & Quality, US
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer
List of Tables
Enigma Diagnostics Limited Pipeline Products and Clinical Trials Overview
Enigma Diagnostics Limited Pipeline Products by Equipment Type
Enigma Diagnostics Limited Pipeline Products by Indication
Enigma Diagnostics Limited, Key Facts
Enigma Diagnostics Limited, Major Products and Services
Enigma Diagnostics Limited Number of Pipeline Products by Development Stage
Enigma Diagnostics Limited Pipeline Products Summary by Development Stage
Enigma ML - C. Difficile/Norovirus - Product Status
Enigma ML - C. Difficile/Norovirus - Product Description
Enigma ML - CT/NG - Product Status
Enigma ML - CT/NG - Product Description
Enigma ML - HPV - Product Status
Enigma ML - HPV - Product Description
Enigma ML - MRSA - Product Status
Enigma ML - MRSA - Product Description
Enigma ML - Rhinovirus - Product Status
Enigma ML - Rhinovirus - Product Description
Enigma ML - Tuberculosis DST Detestion Assay - Product Status
Enigma ML - Tuberculosis DST Detestion Assay - Product Description
Enigma ML System - Product Status
Enigma ML System - Product Description
Enigma ML System - FluAB-RSV Diagnostic Assay - Product Status
Enigma ML System - FluAB-RSV Diagnostic Assay - Product Description
Enigma XL System - Product Status
Enigma XL System - Product Description
MDx Infectious Disease Assay - Product Status
MDx Infectious Disease Assay - Product Description
ResonSense MDR-TB Assay - Product Status
ResonSense MDR-TB Assay - Product Description
Enigma Diagnostics Limited, Key Employees
List of Figures
Enigma Diagnostics Limited Pipeline Products by Equipment Type
Enigma Diagnostics Limited Pipeline Products by Development Stage

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook